Mitopharm Corporation (MTPM) Rated Speculative Buy, Target Price $3.58 by Beacon Equity Research
In the report, the analyst writes, “Mitopharm Corporation (MTPM) is a development-stage biotechnology company involved in the research and development, marketing and sales of functional beverages, dietary supplements and drugs. The Company employs the latest technologies in biochemistry, pharmacology and Traditional Chinese Medicinal (TCM) formulas to research and develop new drugs. The Company’s products, Restorade and Stamina Solution, are based on a newly discovered compound, which has biochemical properties that aid in countering the effects of aging.” Globally, biotechnology is one of the fastest growing sectors of the healthcare market. Biotechnology involves diverse activities including pharmaceutical development, medical devices and…